ArticlePloS one2022

Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants.

Hiroshi Yokokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.